Resources
A clinical microbiologist analyzes two isolates from patients exhibiting acute pharyngitis. Isolate A consists of unicellular organisms bounded by a peptidoglycan cell wall containing ribosomes, which reproduce via binary fission. Isolate B consists of an acellular agent with a single-stranded RNA genome enclosed in an icosahedral protein capsid, lacking metabolic enzymes and requiring host ribosomes for translation. (a) Classify Isolate A and Isolate B as bacterial or viral. (b) Explain the molecular mechanism by which ampicillin, a -lactam antibiotic, would be effective against Isolate A. (c) Explain why ampicillin is completely ineffective against Isolate B.
Answer and steps
Final answer
(a) Isolate A is bacterial; Isolate B is viral. (b) Ampicillin competitively inhibits transpeptidase (penicillin-binding proteins), preventing the cross-linking of peptidoglycan chains in the bacterial cell wall, leading to osmotic lysis during binary fission. (c) Viruses lack a peptidoglycan cell wall, transpeptidase enzymes, and independent metabolic pathways, rendering -lactam antibiotics completely ineffective.
Steps
(a) Classifying the Pathogens
-
Isolate A: Bacterium
- Structural Features: It is unicellular, possesses a peptidoglycan cell wall, and contains ribosomes.
- Mode of Reproduction: It replicates independently through binary fission.
- These cellular characteristics uniquely define prokaryotic bacterial organisms.
-
Isolate B: Virus
- Structural Features: It is acellular, consisting only of a genetic core (single-stranded RNA) enclosed in a protective protein shell (icosahedral capsid).
- Metabolism & Replication: It lacks independent metabolic machinery, has no ribosomes, and must hijack host cell ribosomes to translate its genome.
- These traits characterize an obligate intracellular viral agent.
(b) Mechanism of Action of Ampicillin on Isolate A
- Targeting Transpeptidase: Ampicillin is a -lactam antibiotic that structurally mimics the terminus of bacterial peptidoglycan precursors. It acts as an inhibitor of transpeptidases (also known as penicillin-binding proteins, or PBPs).
- Disrupting Cross-Linking: Transpeptidases catalyze the cross-linking between adjacent glycan strands (composed of alternating -acetylglucosamine and -acetylmuramic acid). Ampicillin binds to and inactivates these enzymes, halting cross-link formation.
- Osmotic Lysis: During binary fission, the bacterium continues to expand and degrade existing wall sections to grow, but fails to synthesize intact, rigid new wall material. This leads to a compromised, structurally weak cell wall that cannot withstand internal turgor pressure, ultimately causing osmotic lysis and cell death.
(c) Ineffectiveness of Ampicillin on Isolate B
- Absence of Molecular Target: Antibiotics operate via selective toxicity, targeting biochemical structures or metabolic enzymes present in bacteria but absent in host cells. Ampicillin specifically targets bacterial peptidoglycan synthesis and transpeptidase enzymes.
- Viral Architecture: Isolate B is an acellular virus bounded by a protein capsid rather than a peptidoglycan cell wall, and it carries no transpeptidase enzymes.
- Because viruses do not synthesize a peptidoglycan cell wall or possess the specific bacterial enzymes targeted by -lactams, ampicillin has no biochemical target and is completely ineffective against them.
Common Pitfall: Prescribing antibacterial agents for viral pharyngitis (such as common cold viruses or adenovirus) is clinically ineffective and contributes significantly to the proliferation of antibiotic-resistant bacterial strains.
Typical errors
01 The student misidentifies the mechanism of ampicillin by confusing beta-lactam antibiotics with 70S ribosome inhibitors such as aminoglycosides or tetracyclines.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
- Step 2Correct
Ampicillin inhibits transpeptidase (penicillin-binding proteins), preventing the cross-linking of peptidoglycan chains in the bacterial cell wall and causing osmotic lysis.
Ampicillin is a -lactam antibiotic that targets cell wall synthesis, not protein synthesis. It binds to transpeptidases (PBPs) to block peptidoglycan cross-linking rather than binding to ribosomes.
- Step 3Correct
Isolate B is an acellular virus that completely lacks a peptidoglycan cell wall, transpeptidase enzymes, and independent metabolic pathways.
While your statement about viral protein synthesis using host ribosomes is biologically true, ampicillin is ineffective against viruses because viruses have no peptidoglycan cell wall or transpeptidases to inhibit.
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly identified Isolate A as bacterial and Isolate B as viral using structural hallmarks.
You recognized that antibiotics require selective molecular targets absent in host cells.
THE ERROR
Where Your ACEpath Teacher Spotted the MistakeYou noted that Isolate A possesses ribosomes and incorrectly attributed ampicillin's antibacterial activity to ribosome binding.
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou confused the molecular target of -lactam antibiotics (peptidoglycan transpeptidases) with antibiotics that inhibit translation by binding bacterial ribosomes (such as aminoglycosides, tetracyclines, or macrolides).
REASONING PATH
Your ACEpath teacher’s suggested approach- Identify the Antibiotic Class and Target
-lactam antibiotics (penicillins, ampicillin, cephalosporins) contain a -lactam ring that mimics and inhibits transpeptidases involved in peptidoglycan cross-linking.
Associate penicillins and ampicillin with cell wall synthesis inhibition and osmotic lysis, while reserving ribosome inhibition for classes like aminoglycosides, tetracyclines, and macrolides.
- Explain Ineffectiveness Against Viruses
Viruses are acellular pathogens with no cell wall, no peptidoglycan, and no endogenous transpeptidases.
State that -lactam antibiotics are completely ineffective against viruses because the specific biochemical target—peptidoglycan cross-linking machinery—is entirely absent.
CORRECTED PATH
ACEpath Teacher's DemonstrationRecall the mechanism of ampicillin: as an extended-spectrum penicillin (-lactam), it binds to and inhibits bacterial transpeptidases (penicillin-binding proteins, or PBPs).
Describe the cellular consequence: without transpeptidase activity, newly synthesized glycan chains cannot form peptide cross-links, weakening the cell wall and causing osmotic lysis during binary fission.
Deduce viral resistance: Isolate B possesses an outer protein capsid and no cell wall or transpeptidases, leaving ampicillin with zero molecular targets.
(a) Isolate A is bacterial; Isolate B is viral. (b) Ampicillin inhibits transpeptidase enzymes (penicillin-binding proteins), blocking peptidoglycan cross-linking and causing osmotic lysis during bacterial division. (c) Ampicillin has no effect on Isolate B because viruses lack a peptidoglycan cell wall, transpeptidase enzymes, and cellular architecture.
02 The student confuses the acellular nature of viruses with the presence of a protective protein coat, mistakenly claiming that the capsid prevents ampicillin from entering rather than noting the absence of a peptidoglycan target.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
Isolate A is bacterial. ⟹ Isolate B is viral.
- Step 2
Ampicillin inhibits transpeptidase enzymes that cross-link peptidoglycan. ⟹ The weakened bacterial cell wall ruptures due to osmotic pressure.
- Step 3
Isolate B has an icosahedral protein capsid that acts as an impermeable barrier. ⟹ The capsid prevents ampicillin from penetrating inside to reach the viral RNA genome.
CorrectViruses lack a peptidoglycan cell wall and transpeptidase enzymes; because ampicillin specifically targets peptidoglycan synthesis, it has no molecular target in viruses.
Ampicillin does not target viral nucleic acids or need to penetrate into the viral interior. It is ineffective because viruses completely lack the specific biochemical target—a peptidoglycan cell wall and transpeptidase enzymes.
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly classified the cellular bacterium and acellular virus from their structural descriptions.
You accurately identified transpeptidase inhibition and osmotic lysis as the antibacterial mechanism of ampicillin.
THE ERROR
Where Your ACEpath Teacher Spotted the MistakeYou assumed the capsid acts as a physical shield blocking ampicillin from viral genetic material.
WHY IT HAPPENED
ACEpath Teacher's DiagnosisConflating selective biochemical toxicity with physical drug penetration, missing that antibiotics are ineffective against viruses because viruses completely lack the cellular structures and enzymes that antibacterial drugs target.
REASONING PATH
Your ACEpath teacher’s suggested approach- Selective Toxicity & Molecular Targets
Antibiotics act on specific prokaryotic structures or metabolic pathways (e.g., peptidoglycan synthesis, translation, bacterial topoisomerases).
When explaining antibiotic ineffectiveness against viruses, state which target structure or enzyme is absent rather than proposing a barrier mechanism.
CORRECTED PATH
ACEpath Teacher's DemonstrationIdentify the biochemical target of ampicillin: bacterial transpeptidase and peptidoglycan cross-linking.
Compare this target to the viral architecture: viruses are acellular assemblies of protein and nucleic acid with no cell wall, peptidoglycan, or transpeptidases.
Conclude that ampicillin has no biochemical receptor or target on Isolate B, rendering it fundamentally inactive.
(c) Viruses lack a peptidoglycan cell wall and transpeptidase enzymes entirely; because ampicillin specifically targets bacterial peptidoglycan cross-linking, it has no molecular target in viruses.
03 The student misinterprets cellular features and reverses the classifications of Isolate A and Isolate B, incorrectly assuming acellular agents with RNA are primitive bacteria.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1
Isolate A is viral. ⟹ Isolate B is bacterial.
CorrectIsolate A is bacterial; Isolate B is viral.
You reversed the two isolates. Isolate A possesses a peptidoglycan cell wall, ribosomes, and divides by binary fission, which are definitive bacterial traits. Isolate B is an acellular entity with an RNA genome and a protein capsid that relies entirely on host ribosomes, which defines a virus.
- Step 2
Isolate A has a capsid instead of a normal cell wall, so ampicillin cannot target it.
CorrectAmpicillin competitively inhibits transpeptidase (penicillin-binding proteins), preventing the cross-linking of peptidoglycan chains in Isolate A's cell wall and causing osmotic lysis.
Because you misclassified Isolate A as viral, you described viral resistance rather than the antibiotic's antibacterial mechanism. In reality, Isolate A has the peptidoglycan wall that ampicillin disrupts by inhibiting transpeptidase enzymes.
- Step 3
Isolate B has a peptidoglycan wall that would normally be inhibited by ampicillin blocking transpeptidase.
CorrectIsolate B lacks a peptidoglycan cell wall, transpeptidases, and cellular metabolism, leaving ampicillin with no molecular target.
Because you misclassified Isolate B as bacterial, you attributed peptidoglycan synthesis to it. In reality, Isolate B is a virus with a protein capsid, so it lacks transpeptidases and peptidoglycan entirely, rendering ampicillin ineffective.
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly identified transpeptidase inhibition as the molecular mechanism of ampicillin against peptidoglycan cell walls.
You correctly recognized that an organism lacking a bacterial cell wall and possessing only a capsid cannot be targeted by cell-wall-inhibiting antibiotics.
THE ERROR
Where Your ACEpath Teacher Spotted the MistakeYou swapped the identities of Isolate A and Isolate B when matching the biological descriptions in the prompt to bacteria versus viruses.
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou associated the acellular RNA-and-capsid profile with bacteria and the cellular peptidoglycan-and-ribosome profile with viruses, reversing the two diagnostic profiles.
REASONING PATH
Your ACEpath teacher’s suggested approach- Hallmarks of Bacteria
Bacteria are cellular prokaryotes with peptidoglycan walls, ribosomes, and the ability to reproduce independently by binary fission.
Whenever you see 'peptidoglycan' or 'binary fission', immediately classify the isolate as bacterial.
- Hallmarks of Viruses
Viruses are acellular genetic packages enclosed in a protein capsid that lack metabolic machinery and ribosomes.
Whenever you see 'acellular', 'capsid', or 'requires host ribosomes', immediately classify the isolate as viral.
CORRECTED PATH
ACEpath Teacher's DemonstrationIdentify Isolate A as bacterial because it has a peptidoglycan cell wall, ribosomes, and replicates via binary fission.
Identify Isolate B as viral because it is acellular, consists of an RNA genome inside an icosahedral protein capsid, and relies on host ribosomes.
Explain that ampicillin targets Isolate A by competitively inhibiting transpeptidase (PBPs), halting peptidoglycan cross-linking and causing osmotic lysis during division.
Explain that ampicillin is ineffective against Isolate B because viruses lack peptidoglycan cell walls and transpeptidase enzymes.
(a) Isolate A is bacterial; Isolate B is viral. (b) Ampicillin inhibits transpeptidase enzymes, preventing peptidoglycan cross-linking in Isolate A and leading to osmotic lysis. (c) Isolate B is an acellular virus lacking a peptidoglycan cell wall and transpeptidases, giving ampicillin no molecular target.
Lock it in
What is the specific molecular target and cellular outcome of -lactam antibiotics like ampicillin?
They competitively inhibit bacterial transpeptidase (PBP) enzymes, preventing peptidoglycan cross-linking and causing osmotic lysis.
Similar question
A patient diagnosed with streptococcal pharyngitis is treated with penicillin V. Describe the biochemical reaction that penicillin V prevents in the bacterial cell wall.
Answer
Penicillin V inhibits transpeptidase enzymes (penicillin-binding proteins), preventing the transpeptidation reaction that forms cross-links between peptide side chains of adjacent peptidoglycan strands.
Gentamicin is an aminoglycoside antibiotic. Contrast its molecular target and mechanism of action with that of ampicillin.
Answer
Gentamicin binds irreversibly to the subunit of bacterial ribosomes, causing misreading of mRNA and halting translation. In contrast, ampicillin inhibits transpeptidases in the cell wall, preventing peptidoglycan cross-linking.
Mycoplasma pneumoniae is a bacterium that causes atypical walking pneumonia. Explain why -lactam antibiotics are completely ineffective against this specific bacterial species.
Answer
Mycoplasma pneumoniae naturally lacks a peptidoglycan cell wall. Because it does not synthesize peptidoglycan or rely on transpeptidase cross-linking for structural integrity, -lactams have no physiological target.